Solid Biosciences Inc at JPMorgan Healthcare Conference Transcript
All right. Welcome, everybody, to the fourth day of the 41st Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Malcolm Kuno and priyanka grover from the team. Our next presenting company is Solid Biosciences and presenting on behalf of the company, we have CEO, Bo Cumbo. Bo?
Thank you Anupam and thank you JPMorgan team for the invite. I really do appreciate the opportunity to present. Before we go into presentation, let me take a moment to talk about forward looking statements, these statements involve risk and uncertainties, many of which will be out of solid control. Actual results could And please take a look at the slide deck. It's posted on our website as well as the 8-K this past week. Now with that said, 2023 is going to be a transformational year and very meaningful advancements for the Solid Biosciences. We just completed a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
